What is Innovative Bioresearch Coin?
Innovative Bioresearch coin (INNBC) is a native digital currency for Innovative Bioresearch Ltd., a biotech company. The company is privately held and aims to bring innovation to critical research areas in medicine, such as cancer, regeneration research, and HIV. The company is looking to achieve global participation at the level of clinical studies of its new therapeutic strategy. Additionally, it will require quick access to the results of previous research and trials in specific areas.
Medical research requires much time and involves patients with varying characteristics. The team at Innovative Bioresearch Ltd. believes that the possible solution to this problem is a decentralized database. Therefore, they have developed a blockchain-based platform that would aid in storing and accessing clinical data. The project uses the app "You're not alone" to access and process data in real time. The app also performs statistical analysis and analyzes suggested treatment profiles. Additionally, it will document and demonstrate periodic updates of the AIDS cure research project.
Powering the project is INNBC, a utility token for the platform. INNBC is the first token to support decentralized biomedical research. It uses the blockchain to decentralize various aspects of the research from funding to data sharing. Innovative Bioresearch price is available on the live chart.
Innovative Bioresearch Ltd. also offers a decentralized exchange (DEX), which allows users to exchange one digital currency for another without the use of intermediaries. The project also provides blockchain development services. The services enable developers to easily launch their blockchain-based products and services.
Use Cases of INNBC Tokens
The project issued the Innovative Biometric crypto asset to support biomedical research. The token is dedicated to cancer and regeneration research program. It is also a means of payment for accessing Innovative Bioresearch medical products and services. Moreover, INNBC can be spent on selected partners, including the Japanese Domestic Market (JDM) online garage.
INNBC does not represent the company’s shares. However, some exchanges list it, and users can trade it. Innovative Bioresearch Coin price may vary due to changes in market conditions. Research the price of the token before you start trading it, as it is a volatile asset, just like other cryptocurrencies. You can find the data on the INNBC price, including the token price history.
Who Founded Innovative Bioresearch?
Jonathan Fior founded Innovative Bioresearch in 2014 in Italy. The company relocated to the United Kingdom in 2018. Jonathan is a research scientist specializing in the niche of HIV cures. He graduated with a Bachelor’s Degree in Medical Biotechnology from the University of Milan. Other key members of the team are Alessandro Gatti and Davide Bosetti.
Tokenomics of INNBC
Innovative Bioresearch Ltd offers two tokens: INNBC and INNBCL. INNBC is dedicated to supporting research projects for cancer and regeneration. INNBCL, on the other hand, supports AIDS research projects.
Innovative Bioresearch launched INNBC with two stages of ICO. The private sales of the tokens began on May 1, 2018, and ended on June 15, 2018. Public sales with a 10% bonus began on June 16 and ended on August 1, 2018. It had a 10% bonus. The revenue raised through the sales of the token was distributed as follows:
- AIDS cure research and developing SupT1 cell infusion therapy – 50%
- Project’s ecosystem – 20%
- App tech development – 15%
- JDM Car stock – 10%
- App maintenance – 5%
The tokenomics design also aims to support the stability of the INNBC price since it is used as a medium of exchange on the Innovative Bioresearch Ltd. platform.